HSD17B13 抗体 (AA 1-200)
Our Local Distributor
北京 101111
Quick Overview for HSD17B13 抗体 (AA 1-200) (ABIN7868557)
抗原
See all HSD17B13 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
抗原表位
- AA 1-200
-
原理
- 17-beta-HSD 13 Antibody / HSD17B13
-
纯化方法
- Protein G affinity
-
免疫原
- A portion of amino acids 1-200 of the human protein was used as the immunogen for the 17-beta-HSD 13 antibody.
-
亚型
- IgG2b, kappa
-
-
-
-
应用备注
- Optimal dilution of the 17-beta-HSD 13 antibody should be determined by the researcher.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 0.2 mg/mL
-
缓冲液
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Aliquot the 17-beta-HSD 13 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- HSD17B13 (Hydroxysteroid (17-Beta) Dehydrogenase 13 (HSD17B13))
-
别名
- 17-beta-HSD 13
-
背景
- Hydroxysteroid 17-beta dehydrogenase 13 (HSD17B13, 17-beta-HSD 13) is an enzyme in the liver that is associated with lipid droplets. It is encoded by the HSD17B13 gene in humans. HSD17B13 levels increase in patients with non-alcoholic fatty liver disease (NAFLD) and can enhance lipogenesis. However, some studies have shown that loss-of-function variants in HSD17B13 may protect against the progression of NAFLD to non-alcoholic steatohepatitis, fibrosis, and hepatocellular carcinoma.
-
UniProt
- Q7Z5P4
抗原
-